|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
12.45(B) |
Last
Volume: |
529,498 |
Avg
Vol: |
473,412 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8.5 |
Insider 3/6 Months : 9.1 |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
1,322 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$248,298 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
1 |
3 |
3 |
Total Buy Transactions |
0 |
1 |
3 |
5 |
Total Shares Sold |
17,698 |
31,794 |
48,856 |
91,693 |
Total Sell Value |
$4,464,485 |
$7,692,626 |
$10,998,196 |
$21,364,499 |
Total People Sold |
5 |
5 |
5 |
8 |
Total Sell Transactions |
6 |
10 |
14 |
26 |
End Date |
2024-02-16 |
2023-11-15 |
2023-05-17 |
2022-05-17 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Massaro George |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
6,187 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
7,894 |
|
- |
|
Andrews Nancy C |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
3,018 |
|
- |
|
Wilson Virginia M |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
3,965 |
|
- |
|
Bertolini Robert J |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$217,675 |
D/D |
953 |
32,802 |
|
- |
|
Thompson Craig B. |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$127,681 |
D/D |
559 |
1,467 |
|
- |
|
Kemps-Polanco Reshema |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$192,778 |
D/D |
844 |
1,014 |
|
- |
|
Llado George |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$197,575 |
D/D |
865 |
3,349 |
|
- |
|
Mackay Martin |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$212,650 |
D/D |
931 |
12,531 |
|
- |
|
Wallman Richard F |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$232,750 |
D/D |
1,019 |
23,547 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2024-05-10 |
4 |
S |
$226.97 |
$295,969 |
D/D |
(1,304) |
23,276 |
|
-2% |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2024-05-02 |
4 |
D |
$232.69 |
$207,792 |
D/D |
(893) |
8,007 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-08 |
4 |
S |
$267.52 |
$216,156 |
D/D |
(808) |
7,024 |
|
13% |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-04 |
4 |
S |
$260.88 |
$717,890 |
D/D |
(2,750) |
7,832 |
|
10% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-03-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
412 |
26,554 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-02-29 |
4 |
S |
$253.43 |
$959,545 |
D/D |
(3,786) |
7,132 |
|
8% |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2024-02-29 |
4 |
S |
$253.70 |
$1,268,500 |
D/D |
(5,000) |
13,550 |
|
8% |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-02-22 |
4 |
S |
$248.50 |
$1,006,425 |
I/I |
(4,050) |
22,879 |
|
6% |
|
Foster James C |
Chairman, President and CEO |
|
2024-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
224,613 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2024-02-15 |
4 |
S |
$238.93 |
$200,223 |
D/D |
(838) |
24,620 |
|
5% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-02-15 |
4 |
OE |
$144.67 |
$850,949 |
D/D |
5,882 |
8,478 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-02-15 |
4 |
AS |
$237.20 |
$1,418,767 |
D/D |
(5,882) |
2,596 |
|
-7% |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2024-02-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
424 |
47,691 |
|
- |
|
Kemps-Polanco Reshema |
Director |
|
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
170 |
170 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-01-29 |
4/A |
D |
$220.28 |
$117,850 |
D/D |
(535) |
8,387 |
|
- |
|
2026 Records found
|
|
Page 1 of 82 |
|
|